Health & BiologyUnlocking the Fortress: How Nano-Messengers are Rewiring the Future of Brain Medicine
This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.
By Nicolás Mario LisnovskyMar 10, 2026